Label:Information for the User
Colestiramine 4 g Powder for Oral Suspension
Colestiramine
Read this label carefully before starting to take this medication,because it contains important information for you.
1.What is Colestiramine and how is it used
2.What you need to knowbeforestarting totake Colestiramine
3.How to take Colestiramine
4.Possible adverse effects
5Storage of Colestiramine
6. Contents of the package and additional information
Resincolestiraminabelongs to a group of medications known as ion exchange resins, which bind to bile acids.
Do not take Resincolestiramina
Warnings and precautions
Consult your doctor or pharmacist before starting to take Resincolestiramina.
Resincolestiramina should never be taken as dry powder, due to the risk of causing a spasm in the esophagus and choking or acute respiratory insufficiency.
During treatment with this medication, your triglycerides in the blood may not decrease or may even increase, usually temporarily.
While taking this medication, your doctor may order you to take a supplement of vitamins A, D, E, and K or folic acid. Follow your doctor's instructions carefully.
This medication may cause constipation or worsen it if you already have it. Follow your doctor's instructions carefully if you have hemorrhoids or a heart disease, as in those cases the medication dose may need to be adjusted or decreased and your liquid and fiber intake increased.
If you have or have had a stomach ulcer, take this medication with caution, as you may experience a relapse.
Other medications and Resincolestiramina
Inform your doctor or pharmacist if you arecurrently taking, have recently taken, or may need to take any other medication.
If you are taking other oral medications, it is essential to take them at a different time than Resincolestiramina. Any medication should be taken at least 1 hour before or 4-6 hours after taking Resincolestiramina, as it may alter the effects of other medications or prevent other medications from being absorbed by the body.
Consult your doctor if you are taking:
- Medications for the treatment of heart rhythm disorders (antiarrhythmics) such as amiodarone.
- Medications for the treatment of pain and/or fever (analgesics and anti-inflammatory drugs) such as paracetamol, diclofenac, phenylbutazone, ibuprofen, meloxicam, piroxicam, tenoxicam, sulindac.
- Medications to prevent blood clots (anticoagulants) such as warfarin.
- Medications for the treatment of depression (antidepressants) such as doxepin and imipramine.
- Medications for the treatment of diabetes (antidiabetics) such as glipizide, acarbose.
- Medications for the treatment of malaria and other parasitic infections such as chloroquine and metronidazole.
- Medications to treat some heart conditions called beta-blockers such as propranolol.
- Medications for the treatment of heart failure (cardiotonics) such as digoxin.
- Corticosteroids such as hydrocortisone.
- Medications to increase urine volume (diuretics) such as furosemide, hydrochlorothiazide.
- Hormones such as estrogens, progesterone.
- Thyroid hormones such as levothyroxine, liothyronine.
- Medications to treat high cholesterol and triglycerides in the blood (statins) such as fluvastatin, pravastatin.
- Medications to treat diarrhea (antidiarrheals) such as loperamide.
- Antibiotics such as tetracyclines.
- Medications to prevent transplant rejection (immunosuppressants), such as mycophenolate mofetil.
- Medications for the prevention of osteoporosis such as raloxifene.
- Medications for the treatment of epilepsy such as valproic acid, barbiturates.
Pregnancy, lactation, and fertility
Do not take Resincolestiramina during pregnancy or lactation.
If you are pregnant or breastfeeding, think you may be pregnant, or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
Resincolestiramina does not affect your ability to drive vehicles or operate machinery.
Resincolestiramina contains propylene glycol and sodium
This medication contains 22.74 mg of propylene glycol (E 1520) (as alginates) in each sachet. If the baby is under 4 weeks old, consult your doctor or pharmacist, especially if the baby has been given other medications containing propylene glycol or alcohol.
This medication contains less than 1 mmol of sodium (23 mg) per sachet; it is essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist.In case of doubt, consult your doctor or pharmacist again.
This medication is administered orally.Resincolestiramina should never be taken as dry powder, due to the risk of causing a spasm in the esophagus and choking or acute respiratory insufficiency.The prescribed medication dose should be added to half a glass of water, milk, or fruit juice, and should be taken orally before meals.It should be shaken before administration.Resincolestiramina may interact with other medications, for which it is recommended to administer them at least 1 hour before or 4 to 6 hours after taking colestiramina (see section 2 “Other medications and resincolestiramina”)
For the treatment of hypercholesterolemia and pruritus associated with partial bile duct obstruction or primary biliary cirrhosis, the recommended dose in adults is 4g of colestiramina (one packet) 3 to 4 times a day (equivalent to 12 – 16g of colestiramina per day).
For the treatment of diarrhea due to bile acid malabsorption, the recommended dose in adults is 4g of colestiramina (one packet) 3 to 6 times a day (equivalent to 12 – 24g of colestiramina per day). Your doctor will indicate the dose to take.If you do not observe improvement in 3 days, consult your doctor.
Use in children and adolescents
For the treatment of decreased cholesterol levels and itching caused by bile retention,the recommended dose is 2g of colestiramina (half a packet) 2 to 4 times a day (equivalent to 4 – 8g of colestiramina per day), although it is preferable to administer the total daily dose in only 2 doses, before breakfast and dinner.
For the treatment of diarrhea due to excess bile acids in the intestine, the dose for children aged 6 to 12 years will be indicated by your doctor, based on the child's weight.For children over 12 years, the recommended dosage is the same as for adults.
The efficacy and safety have not been established in children under 6 years.
If, after starting treatment for diarrhea due to malabsorption, diarrhea persists for more than 3 days, consult your doctor.
If you take more Resincolestiramina than you should
In case of accidental ingestion, consult your doctor or pharmacist immediately or contact the nearest hospital emergency service and bring the medication with you.You can also call the Toxicological Information Service Telephone 91.562.04.20, indicating the medication and the amount ingested.
If you forgot to take Resincolestiramina
Take the missed dose as soon as you remember, except if the time of your next dose is near.In that case, do not take the missed dose and continue taking the medication as indicated.
Do not take a double dose to compensate for the missed doses.
To reduce these side effects, you will start taking Resincolestiramina with a low dose that will be gradually increased. These side effects usually disappear over time.
Gastrointestinal side effects are the most common.The most frequently observed adverse reaction is constipation. Constipation may favor the appearance of fecaloma (hard stools) and may exacerbate the symptoms of pre-existing hemorrhoids.
Side effects may occur with certain frequencies, which are defined as follows:
Frequent(may affect up to 1 in 10 people)
Infrequent(may affect up to 1 in 100 people)
Rare(may affect up to 1 in 1000 people)
Unknown frequency(cannot be estimated from available data)
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: www.notificaRAM.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
This medication does not require special storage conditions
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash.Deposit the packaging and unused medicines at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and unused medicines. By doing so, you will help protect the environment.
Composition of Resincolestiramina
Appearance of the product and contents of the packaging
Resincolestiramina is presented in packaging containing 50 packets.
Holder of the marketing authorization and responsible for manufacturing
Laboratorios Rubió, S. A.
C/ Industria, 29
Polígono Industrial Comte de Sert
08755 Castellbisbal – Barcelona
Spain
Last review date of thisleaflet: February 2023
The detailed information of this medication is available on the website ofthe Spanish Agency of Medicines and Medical Devices (AEMPS) http: //www.aemps.gob.es
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.